Skip to main content

Table 1 The demographic and laboratory data in ESRD and NC groups

From: The characteristics of extrachromosomal circular DNA in patients with end-stage renal disease

Variables

ESRD (n = 16)

NC (n = 12)

P value

Age, years (± SD)

45 ± 10

33 ± 13

0.007

Male, n (%)

8 (50.00)

4 (33.33)

0.3778

HTN, n (%)

14 (87.50)

/

/

DN, n (%)

4 (25.00)

/

/

CGN, n (%)

10 (62.50)

/

/

LN, n (%)

2 (12.50)

/

/

Duration of hemodialysis, years (M [P25, P75])

4 (2.75, 5.00)

/

/

Hb, g/dL (± SD)

93.63 ± 16.31

137.00 ± 14.72

 < 0.0001

Neutrophil percentage,

% (± SD)

66.29 ± 7.46

56.22 ± 10.16

0.0076

Scr, µmol/L (± SD)

1027.76 ± 367.35

71.97 ± 13.75

 < 0.0001

BUN, mmol/L (± SD)

21.81 ± 7.62

3.95 ± 0.73

 < 0.0001

eGFR, mL/min/1.73m2 (± SD)

4.93 ± 2.99

/

/

Albumin, g/dL (± SD)

39.28 ± 6.57

/

/

PTH, pg/mL (± SD)

381.57 ± 300.49

/

/

  1. ESRD, end-stage renal disease; NC, normal control; HTN, hypertension; DN, diabetes nephropathy; CGN, chronic glomerulonephritis; LN, lupus nephritis; Hb, hemoglobin; Scr, serum creatinine; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; PTH, parathyroid hormone